Abstract
Background:
Propofol is widely used for gastrointestinal endoscopy due to its rapid onset and recovery, but it may cause cardiopulmonary events. This study assessed outcomes and adverse events in patients sedated with propofol.
Objectives:
To find out the incidence of sedation related complications of propofol use during advanced endoscopic procedures.
Methods:
A cross-sectional study was conducted on 109 patients undergoing endoscopic procedures. Demographics, ASA status, BMI, sedation dose, recovery profile, and complications were recorded and analyzed.
Results:
In this study Chi-square test was used by SPSS 27.0 version and the mean age was 39.5 years, and mean BMI was 28 kg/m². Most patients were ASA II–III, and ERCP was the most common procedure. Hypoxia occurred in 41.3%, hypotension in 54.1%, and vasopressors were required in 45%. Airway interventions were needed in most cases (75.2%), though intubation was rare (3.7%). All events were transient and managed safely. Propofol alone showed fewer complications and better recovery than combination regimens.
Conclusion:
Propofol is safe and effective for endoscopy when used with vigilant monitoring. Higher BMI, ASA III–IV status, and supine positioning increase risks, while propofol administration is safer than combination sedation.